Statistical analysis
tumor
TUMOR, DISEASE CHARACTERISTIC
Unless otherwise specified, graphs and statistical analyses were performed using GraphPad Prism.All randomized patients with mThe safety analysis set comprised randomized patients who received at least one dose of vorasidenib or ivosidenib either pre- or postoperatively. Baseline disease characteristics and safety data were summarized by treatment and dose.Concentrations of vorasidenib and ivosidenib in tumor and plasma were reported as geometric mean and tumor:plasma ratios summarized by treatment and dose. Association of 2-HG with 5hmC, Ki-67 and CD3